20 September 2021
Professor Tim Maughan outlines the flagship work of the FOCUS4 trials, whose results were presented this weekend at the European Society of Medical Oncology (ESMO) annual meeting
18 September 2021
The latest results from the multi-arm FOCUS4 trial, led by Tim Maughan at the University of Oxford, has shown that the drug adavosertib has promising activity in bowel cancer patients
Become part of the Oxford Cancer community & contribute to a world where cancers are diagnosed earlier and treated more effectively
Our research will
mean better care
for cancer patients
Read about some of Oxford's flagship
clinical trials and research projects, which
are helping to understand the fundamentals
of cancer better and ultimately deliver
better patient care.
If you are an Oxford-based researcher working in cancer research, or field relevant to cancer science, Oxford Cancer are here to support your work through coordinating infrastructure and lowering access barriers to key research facilities and expertise.
We provide access to a range of services and support that could enrich your research and help it reach its translational potential. These are available to any University of Oxford or Oxford University Hospitals (OUH) staff member who is part of our Oxford Cancer community.
Scroll through our list of services below, or check out our dedicated Services & Support section.